Details

NameSymbolSector
ASTRAZENECA PHARMA INDIA LTD.ASTRAZENPharmaceuticals
Open
8260
High
8461
Low
8234.5
Close
8423.5
Volume
7062
Exchange
nse
Time
15-Jun-2026

Outlook

Score:  

3.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Astrazeneca Pharma India is  
Normal
Estimated Stoploss of Astrazeneca Pharma India is ₹  
8234.5
Astrazeneca Pharma India has a  
Bullishℹ
 pattern. 
Formation of  
Normal
 candle pattern indicates the trend direction of Astrazeneca Pharma India is  
Unpredictableℹ
. 

Trend

Astrazeneca Pharma India is in  
Sideways trendℹ
. 
Price of Astrazeneca Pharma India is  
Downℹ
 by  

0.4

%. 
Target
Buy @ 

7865.92

Sell @ 

8916.34

Current @ 

8423.5

Volume

The trade volumes of Astrazeneca Pharma India have become  
Deficientℹ
The volume trend for Astrazeneca Pharma India is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Astrazeneca Pharma India is  

Down

 by  

31.22

% 

Valuation

The current market price of Astrazeneca Pharma India is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 1518cr and total assets worth ₹ 1518cr, the balance sheet of Astrazeneca Pharma India is:  
Balancedℹ
. 
Cashflow
Astrazeneca Pharma India has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 30cr

. It is  
Upℹ
 by  

500

%. 

(*Mar 2025)

40.63% i.e. ₹ 65cr earned in operatingℹ
18.75% i.e. ₹ 30cr earned in investingℹ
40.63% i.e. ₹ 65cr spent in financingℹ
0% in otherℹ
Astrazeneca Pharma India has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 5cr

. It is  
Downℹ
 by  

90.2

%. 

(*Mar 2024)

29.35% i.e. ₹ 27cr earned in operatingℹ
22.83% i.e. ₹ 21cr earned in investingℹ
47.83% i.e. ₹ 44cr spent in financingℹ
0% in otherℹ
Income
The income of Astrazeneca Pharma India is  

₹ 565cr

 and  

Profit

 is :  

₹ 54cr

(*Sep 2025)

Astrazeneca Pharma India Profit is down by:  

1.82

% and Income is Up by:  

5.21

% 

(*Sep 2025)

The income of Astrazeneca Pharma India is  

₹ 537cr

 and  

Profit

 is :  

₹ 55cr

(*Jun 2025)

Astrazeneca Pharma India Profit is down by:  

5.17

% and Income is Up by:  

8.27

% 

(*Jun 2025)

The income of Astrazeneca Pharma India is  

₹ 496cr

 and  

Profit

 is :  

₹ 58cr

(*Mar 2025)

Astrazeneca Pharma India Profit is up by:  

93.33

% and Income is Up by:  

10.71

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.